Quick Answer
VitaNova Life Sciences Corp reported Operating Income of $1.21 million for fiscal year 2025.
VitaNova Life Sciences Corp Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | $1.21M | +487.6% |
| 2024 | $205.6K | +948.8% |
| 2023 | -$24.2K | -81.2% |
| 2022 | -$13.4K | +74.3% |
| 2021 | -$52.1K | +28.0% |
| 2020 | -$72.3K | -0.7% |
| 2019 | -$71.8K | -47.6% |
| 2018 | -$48.6K | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| January 31, 2026 | $46.7K | -57.1% | -52.9% |
| October 31, 2025 | $99.2K | +58.4% | -8.9% |
| January 31, 2025 | $108.9K | +1730.4% | +73.9% |
| October 31, 2024 | $62.6K | +815.0% | +952.5% |
| January 31, 2024 | $5.9K | — | +167.9% |
| October 31, 2023 | -$8.8K | — | +63.9% |
| July 31, 2023 | -$24.2K | -1236.2% | -1236.2% |
| July 31, 2022 | $2.1K | +120.4% | +107.1% |
- VitaNova Life Sciences Corp showed an increase of +487.6% in Operating Income compared to the prior fiscal year.
- Over the 2018–2025 period, VitaNova Life Sciences Corp’s operating income has grown by 2583.7% (from -$48.6 thousand to $1.21 million).
- The most recent figure is from VitaNova Life Sciences Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on July 24, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: